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Introduction
Cell migration is a key component of development, wound heal-
ing, and immunological responses (Ridley et al., 2003). It also 
plays essential roles in pathological processes, e.g., invasion of 
primary tumor cells and subsequent metastasis to distant sites 
(Sporn, 1996). Elucidation of the molecular mechanisms in-
volved in the initiation and control of cell migration is therefore 
essential to understanding these processes (Horwitz and Webb, 
2003). Migrating cells extend protrusions in the forward direc-
tion, form new attachments to the extracellular matrix, and 
 release attachments at the rear to allow the cell mass to pull 
 forward (Ridley et al., 2003). The newly formed attachments at 
the cell anterior lead to adhesion-induced activation of Rac1 
that causes localized actin polymerization to create broad pro-
trusive structures (lamellipodia; Pollard and Borisy, 2003). 
When detached cells adhere, adhesion-induced Rac activation 
leads to unpolarized lamellipodial extension, resulting in cell 
spreading (Etienne-Manneville and Hall, 2002). Thus, cell 
spreading and lamellipodial extension are closely related Rac-
mediated events.
The Ras family GTPase Related-Ras (R-Ras) can regulate 
adhesion-mediated Rac activation and cell migration (Holly 
et al., 2005; Wozniak et al., 2005). R-Ras shares 55% sequence 
homology with related paralogues in the Ras family of small 
GTPases, has an almost identical effector-binding region to 
H-, N-, and K-Ras (Lowe et al., 1987; Self et al., 1993), and 
couples to common Ras effectors, including Raf1, RalGDS, 
RapL/NORE1, and PI3-kinase (Oertli et al., 2000). However, 
R-Ras has distinct cellular functions from other Ras paralogues. 
In addition to its distinct effects on integrin activation, R-Ras 
inhibits cell proliferation in endothelial and smooth muscle 
cells (Komatsu and Ruoslahti, 2005) and promotes cell adhe-
sion (Zhang et al., 1996; Keely et al., 1999), cell spreading, hap-
totactic migration (Holly et al., 2005; Ada-Nguema et al., 2006), 
and neurite outgrowth (Ivins et al., 2000; Oinuma et al., 2004). 
R-Ras mediates these effects on cells through coupling to down-
stream effectors; however, to date, no bona fi de R-Ras effectors 
have been described to account for its functions distinct from 
H-Ras and Rap1.
A hindrance to the identifi cation of effectors for small 
GTPases is the absence of isoprenylation or correct subcellular 
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targeting of Ras GTPases in commonly used methods, such as 
yeast two-hybrid screens (Gietz et al., 1997). The subcellular 
localization of these proteins is essential for correct target-
ing to specifi c effectors and for resulting biological functions 
(Hancock, 2003). To facilitate the hunt for isotype-specifi c 
effectors of Ras GTPases, we have used tandem affi nity 
 purifi cation (TAP) tags (Rigaut et al., 1999; Puig et al., 2001) 
and high-throughput mass spectroscopy to isolate and char-
acterize proteins that interact with posttranslationally modi-
fi ed Ras GTPases in murine fi broblasts. The results of these 
studies permitted us to develop and analyze a comparative 
proteomic database of Ras-interacting proteins that is publicly 
available (http://www.cellmigration.org/resource/discovery/
proteomics/ginsberg_ras_data.shtml). Using this database, we 
have identifi ed RLIP76 (RalBP1; Cantor et al., 1995; Jullien-
Flores et al., 1995) as a novel R-Ras effector. We show that 
RLIP76 directly binds R-Ras in a GTP-dependent manner, but 
does not interact with the closely related Ras isotypes H-Ras or 
Rap1A, confi rming that RLIP76 is an authentic effector with 
relative R-Ras specifi city. Furthermore, RLIP76 mediates the 
effect of R-Ras on cell spreading and migration by functioning 
as a key link in a cascade of small GTPases in which RLIP76 
binding to R-Ras capacitates adhesion-mediated activation of 
Arf6 GTPase. Activated Arf6 GTPase is then required for ad-
hesion-induced Rac activation and the resulting lamellipodia 
and cell migration.
Results
An experimental database of Ras-
interacting proteins identifi es RLIP76 
as an R-Ras interactor
To identify potential effectors of R-Ras, we exploited a compar-
ative proteomic effort (http://www.cellmigration.org/resource/
discovery/proteomics/ginsberg_ras_data.shtml) to isolate and 
characterize Ras-binding proteins. In brief, this database used a 
modifi ed TAP scheme originally described for yeast proteomics by 
Rigaut et al. (1999) for a mammalian system (Puig et al., 2001). 
To do this, we fused the TAP tag-coding region to the N termi-
nus of human Ras cDNAs containing point  mutations to render 
them constitutively active (R-Ras[G38V]) and dominant nega-
tive (R-Ras[T43N]); in the case of R-Ras, we used two effector 
loop mutants, R-Ras(G38VD64A) and R-Ras(G38VD64E), 
built on the activated background. To assess specifi city amongst 
Ras family members, similar constructs were prepared for ac-
tivated variants of H-Ras(G12V) or Rap1A(G12V). The Ras 
con structs were expressed in murine 3T3 cells and purifi ed, 
and associated proteins were identifi ed by mass spectroscopy 
(http://www.cellmigration.org/resource/discovery/proteomics/
ginsberg_ras_data.shtml).
This unbiased proteomic screen identifi ed RLIP76 
(RalBP1) as a protein interacting with activated R-Ras(G38V), 
but not with dominant-negative R-Ras(T43N). Furthermore, 
RLIP76 was not identifi ed amongst the proteins co-isolating 
with activated variants of H-Ras(G12V) or Rap1A(G12V) 
(http://www.cellmigration.org/resource/discovery/proteomics/
ginsberg_ras_data.shtml), suggesting RLIP76 might be involved 
in R-Ras–specifi c signaling. To confi rm the specifi city of 
RLIP76 interactions with R-Ras, we coexpressed authentic 
human RLIP76 cDNA with R-Ras variants in murine 3T3 
cells. RLIP76 coprecipitated with activated R-Ras(G38V), 
but not R-Ras(T43N; Fig. 1 B), demonstrating the GTP de-
pendence of the interaction. Furthermore, activated variants 
of H-Ras(G12V) and Rap1A(G12V) did not interact with 
RLIP76, establishing the specifi city of the interaction amongst 
Ras family members and confi rming a previous report of the 
failure of RLIP76 to bind H-Ras in a yeast two-hybrid expe-
riment (Fig. 1 B; Jullien-Flores et al., 1995). In contrast to 
H-Ras, activated R-Ras promotes integrin activation (Zhang 
et al., 1996; Sethi et al., 1999) and cell spreading (Holly 
et al., 2005; Ada-Nguema et al., 2006). Mutations in the switch 
1 effector-binding region of R-Ras can selectively disrupt its 
ability to interact with known effectors and can alter its ability 
to increase integrin activation (Oertli et al., 2000). We exam-
ined the effect of such switch 1 mutants of R-Ras on integrin-
mediated cell spreading. In confi rmation of previous work 
(Holly et al., 2005), transfection of NIH 3T3 mouse fi broblasts 
with constitutively active R-Ras(G38V), but not R-Ras(T43N; 
dominant negative), stimulated cell spreading (Fig. 1 C). The 
effector loop mutant R-Ras(G38VD64A), which fails to bind 
or activate PI3-kinase and RalGDS but is competent to acti-
vate integrins (Oertli et al., 2000), promoted cell spreading, 
whereas R-Ras(G38VD64E) failed to do so. Thus, the increase 
in spreading caused by R-Ras does not require direct activa-
tion of PI3-kinase or Ral. In TAP-Ras pulldown experiments 
we isolated RLIP76 with R-Ras variants that support cell 
spreading, i.e., R-Ras(G38V) and R-Ras(G38VD64A), but we 
did not detect RLIP76 in proteins isolated with R-Ras(T43N) 
or R-Ras(G38VD64E; unpublished data). To directly assess 
whether RLIP76 was a candidate effector for this R-Ras func-
tion, we examined its ability to coprecipitate with each of 
these variants. RLIP76 coprecipitated with R-Ras(G38V) and 
the G38VD64A mutant, but not with the dominant-negative 
T43N variant or the G38VD64E double mutant (Fig. 1 D). 
Thus, RLIP76 interacts with R-Ras variants that support cell 
spreading and integrin activation and is a candidate to mediate 
these activities of R-Ras.
RLIP76 is required for R-Ras–induced 
cell spreading
The specifi city of the interactions of RLIP76 with the R-Ras 
variants that promote spreading and integrin activation sug-
gested that RLIP76 may play a role in these processes. We used 
double-stranded siRNA (Rosse et al., 2003) to inhibit RLIP76 
expression in mouse 3T3 cells. This siRNA reduced the expres-
sion of endogenous RLIP76 by >90% in mouse 3T3 cells and 
CHO cells and, as previously reported (Rosse et al., 2003), also 
suppressed the expression of human RLIP76 (Fig. 2 A and 
 unpublished data). 
To assess a role for RLIP76 in cell spreading, 3T3 cells 
were transfected with the RLIP76 siRNA, plated onto fi bro-
nectin-coated coverslips, and evaluated for spreading. The 
cells transfected with the RLIP76 siRNA showed markedly re-
duced cell spreading, and this effect could not be reversed by 
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cotransfection of R-Ras(G38V; Fig. 2, A and B). In contrast, 
reconstitution of RLIP76 expression with a cDNA encoding 
three silent mismatches (RLIP76m) in the siRNA target se-
quence, restored RLIP76 expression and cell spreading (Fig. 2, 
A and B). R-Ras can regulate integrins’ affi nity (Zhang et. al. 
1996), but siRNA-mediated knockdown of RLIP76 had no 
 effect on the activation state of integrins in CHO cells (Hughes 
et al., 1997; unpublished data). Furthermore, R-Ras can re-
verse the suppressive effect of H-Ras on integrin activation 
(Sethi et al., 1999); however, RLIP76 siRNA had no effect on 
this activity of R-Ras (unpublished data). Thus, RLIP76 is re-
quired for cell spreading and for the increased spreading medi-
ated by activated R-Ras, but did not modulate integrin affi nity 
in CHO cells.
The requirement of RLIP76 expression for spreading sug-
gested that RLIP76 may be downstream of signals from R-Ras 
in cell spreading. As a test of this hypothesis, we expressed 
dominant-negative R-Ras(T43N) and found that it inhibited 
cell spreading (Fig. 1 C and Fig. 2 C) and the defect in cell 
spreading induced by R-Ras(T43N) was reversed by overex-
pression of RLIP76 (Fig. 2 C). Thus, RLIP76 is required for 
R-Ras–mediated cell spreading, and RLIP76 overexpression 
can bypass a requirement for R-Ras activity in cell  spreading. 
These relationships, in combination with the R-Ras effector 
loop specifi cities of the physical interaction of R-Ras with 
RLIP76, demonstrate that RLIP76 is downstream of R-Ras in 
promoting cell spreading.
The RhoGAP-binding, but not the Ral-
binding, domain of RLIP76 is required 
for binding to R-Ras and for cell spreading
The association of RLIP76 with activated R-Ras and its role in 
R-Ras–mediated spreading suggested the possibility that these 
proteins may interact directly and that RLIP76 might be an au-
thentic R-Ras effector. In prokaryotic expression systems, we 
were unable to obtain a suffi cient quantity of purifi ed full-length 
RLIP76 protein to analyze its interaction with R-Ras because 
of low expression levels (unpublished data), and therefore 
used coimmunoprecipitation studies to initially map the 
RLIP76-binding domain for R-Ras. The RLIP76 polypeptide 
consists of an N-terminal coiled coil region, a Rho GTPase-
 activating protein (RhoGAP) domain, a short connecting segment, 
Figure 1. Identifi cation of RLIP76 as an R-Ras 
effector in cell spreading. (A) Schematic repre-
sentation of the TAP–R-Ras fusion construct. The 
modifi ed TAP tag consists of an N-terminal 
poly-histidine tag (6-His tag), a protein A mod-
ule, the recognition sequence for the TEV 
 protease, and a calmodulin-binding domain 
(CBD). The following important features of the 
R-Ras moiety are shown: two proline-rich SH3-
binding sequences (PP), one of which is con-
tained within the C-terminal hypervariable 
region (HVR); the switch 1 effector-binding 
loop region (SW1), which is important for 
 effector binding; the switch 2 region (SW2), 
which is involved in binding guanine nucleo-
tide; the Cys213 palmitoylation site (*) and the 
Cys215 methylation and geranylgeranylation 
site (¥); and the R-Ras isoprenylation motif. 
(B) TAP fusions of constitutively active variants 
of R-Ras, H-Ras, Rap1A, and dominant-
 negative R-Ras(T43N) were cotransfected with 
HA-RLIP76 cDNA into NIH 3T3 cells. TAP-Ras 
proteins were isolated from cell lysates by 
IgG–Sepharose affi nity chromatography, and 
protein complexes were fractionated by SDS-
PAGE and Western blotted with antibodies to 
the TAP tag (α-MLCKsk) or HA. HA-RLIP76 was 
detected in R-Ras(G38V) precipitates, but not 
in precipitates of H-Ras(G12V), Rap1A(G12V), 
or R-Ras(T43N), indicating that RLIP76 binds in 
a GTP-dependent manner exclusively to R-Ras 
among the members of this Ras subfamily. 
IP, immunoprecipitate; WCL, whole cell lysate. 
(C) NIH 3T3 cells were cotransfected with 
cDNA encoding GFP and the following vari-
ants of human R-Ras: constitutively active 
(G38V), dominant-negative (T43N), and effec-
tor loop mutants (D64A and D64E) on the acti-
vated G38V background. Cells were plated 
onto fi bronectin-coated coverslips, fi xed after 45 min, and stained with rhodamine-phalloidin to reveal F-actin. The cell periphery, as delineated by phalloi-
din labeling, was used to calculate the area of GFP-positive cells. At least 40 cells were counted for each sample. Mean area measurements are representa-
tive of at least three independent experiments and are shown ± the SEM. (D) HA-RLIP76 was cotransfected with the indicated R-Ras protein variants in NIH 
3T3 cells. R-Ras was immunoprecipitated from each sample with anti–R-Ras antibodies, and the bound proteins were eluted in SDS buffer and separated 
by SDS-PAGE, and then Western blotted with antibodies to R-Ras or to HA. HA-RLIP76 was detected in R-Ras(G38V) and -G38VD64A precipitates, but not 
in -T43N or -G38VD64E precipitates.
JCB • VOLUME 174 • NUMBER 6 • 2006 880
a Ral-binding domain (RBD), and a C-terminal region (Fig. 3 A; 
Cantor et al., 1995; Jullien-Flores et al., 1995; Park and Weinberg, 
1995). We constructed N-terminal RLIP76 lacking the RBD and 
C-terminal region (∆RBD) or that were further truncated at the 
C-terminal half of the GAP domain (∆GAPn; Fig. 3 A). In coim-
munoprecipitation experiments, the full-length RLIP76 and the 
RBD-deleted protein (∆RBD) coprecipitated with activated 
R-Ras, whereas the ∆GAPn truncated protein did not (Fig. 3 B). 
These data suggested that the RBD, responsible for direct inter-
action of RLIP76 with Ral GTPase, (Jullien-Flores et al., 1995), 
is not required for RLIP76 interaction with R-Ras. To test 
whether RLIP76 can interact directly with R-Ras, we gener-
ated N-terminal poly-histidine–tagged bacterial expression 
 constructs encoding RLIP76∆RBD or -∆GAPn; both were 
well expressed. An N-terminal glutathione-S-transferase fusion 
to R-Ras(wt) (GST–R-Ras) protein was coupled to GSH beads 
and either loaded with 10 μM GTP to generate activated R-Ras 
or maintained in 10 mM EDTA to produce nucleotide-free 
R-Ras. Western blotting showed that the ∆RBD fragment pro-
tein bound directly to R-Ras in a GTP-dependent manner. 
In contrast, the ∆GAPn RLIP76 fragment did not detectably 
 interact with R-Ras in either state (Fig. 3 C). Thus, RLIP76 
binds  directly to R-Ras, in a GTP-dependent manner, and the 
RLIP76 RhoGAP domain, but not to the RBD, is  required for 
this interaction.
We next evaluated the abilities of the truncated RLIP76 
mutants to reconstitute spreading in RLIP76-depleted cells. 
The RLIP76 mutants were constructed on the siRNA  mismatch 
RLIP76 mutant background and cotransfected with RLIP76 
siRNA. RLIP76m∆RBD, which binds R-Ras, rescued the 
siRNA-induced spreading defect to a similar extent to the full-
length construct (Fig. 3 D). The ∆GAPn truncation mutant, which 
did not bind R-Ras (Fig. 3, A and B), did not reverse the effect 
of RLIP76 siRNA. Thus, R-Ras binds the RhoGAP, but not the 
RBD of RLIP76 in a GTP-dependent manner, and the RhoGAP 
domain is required for RLIP76-dependent cell spreading.
Cell spreading can be induced by the small GTPase 
Rac1 (Hall, 1998). The RhoGAP domain of RLIP76 has Rac 
GAP activity in vitro (Jullien-Flores et al., 1995; Matsubara 
et al., 1997; Park and Weinberg, 1995). The RLIP76 RhoGAP 
domain bears strong sequence similarity to the RhoGAP 
 domains of BCR-GAP and n-chimaerin, which are both GAPs 
for Rac (Jullien-Flores et al., 1995; Park and Weinberg, 1995). 
Despite sequence divergence among GAP proteins, their 
mechanism of action is highly conserved, and depends on 
an “arginine fi nger,” which is a conserved arginine residue in 
Figure 2. RLIP76 is required for R-Ras–
 induced cell spreading. (A) NIH 3T3 cells were 
transfected with R-Ras(G38V) in the presence 
or absence of 50 pmol of a double-stranded 
siRNA targeting both human and mouse 
RLIP76 (RLIP76 siRNA; Rosse et al., 2003) or a 
sequence-scrambled siRNA (scrbl). Cell lysates 
were blotted with anti-RLIP76 antibodies. RLIP76 
expression was restored in siRNA-transfected 
cells by coexpression of RLIP76 cDNA con-
taining three silent mutations in the siRNA 
 target site (RLIP76m). Cells were plated on 
 fi bronectin-coated coverslips and cell area was 
measured as described in Materials and meth-
ods. Mean area measurements of GFP-positive 
cells are representative of at least three inde-
pendent experiments and are shown ± the 
SEM. (B) Representative micrographs (a and c, 
GFP to mark transfected cells; b and d, 
 rhodamine-phalloidin to detect F-actin) of 
cells spreading on fi bronectin; cells were trans-
fected with RLIP76 siRNA in the absence 
(a and b) or presence of the RLIP76m rescue 
construct (c and d). Bar, 5 μm. (C) NIH 3T3 
cells were transfected with dominant-negative 
R-Ras(T43N), with or without cotransfection 
with RLIP76, and cell spreading was measured 
as described in Materials and methods. Mean 
area measurements of GFP-positive cells are 
representative of at least three independent 
 experiments and are shown ± the SEM. 
 Expression levels of the transfected proteins 
were assayed by Western blotting with anti-
bodies to R-Ras (top) or HA (bottom).
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a loop segment that stabilizes the GTP moiety on the sub-
strate, increasing the substrate’s intrinsic GTPase activity 
(Bourne, 1997). RLIP76, bearing a mutation in the conserved 
Arg required for GAP function (RLIP76m[R232D]), still sup-
ported cell spreading in RLIP76-depleted cells, indicating 
that GAP activity of RLIP76 is not required for its effects on 
cell spreading (Fig. 3 E).
RLIP76 regulates R-Ras–induced cell 
spreading by promoting adhesion-induced 
Rac activation
Activated R-Ras stimulates cell spreading and migration by 
augmenting the activation of the small GTPase Rac1 (Holly 
et al., 2005), although this effect appears to be cell type specifi c 
(Wozniak et al., 2005). In murine 3T3 cells, as reported by Holly 
et al. (2005), transfection of R-Ras(G38V) resulted in an ap-
proximately threefold increase in adhesion-induced activation 
of Rac1, as measured by its binding to the p21-binding domain 
of PAK1 (Fig. 4 A; Bagrodia et al., 1998; del Pozo et al., 2000). 
Cotransfection of RLIP76 siRNA completely blocked this effect 
of R-Ras(G38V); this decrease could be reversed by reexpres-
sion of RLIP76m (Fig. 4 A). Thus, RLIP76 expression is 
 required for R-Ras–induced Rac activation.
As noted above, the capacity of dominant-negative 
(T43N) R-Ras to inhibit spreading and Rac activation suggests 
that endogenous R-Ras mediates these processes. To determine 
whether RLIP76 is required for adhesion-dependent activation 
of Rac, we assessed the effect of siRNA-mediated RLIP76 
knockdown on adhesion-induced Rac activation in the absence 
of exogenous R-Ras. In control siRNA-transfected cells, 
Rac activation was low in cells maintained in suspension, and 
increased dramatically after fi ve minutes of adhesion to fi bro-
nectin (Fig. 4 B). This increase in Rac activation was followed 
by a diminution over the next 10 min. In contrast, cells with 
Figure 3. The RhoGAP, but not the RBD of RLIP76, is 
 required for binding to R-Ras and for cell spreading. 
(A) Schematic diagram of RLIP76 truncation mutants. Each 
of the indicated constructs was generated with N-terminal 
HA tags for mammalian expression and N-terminal His 
tags for bacterial expression and purifi cation. (B) Coim-
munoprecipitation of RLIP76 truncation mutants and R-Ras. 
Full-length RLIP76 and RLIP76∆RBD coprecipitated with 
activated R-Ras, but the RLIP76∆GAPn truncation did not. 
IP, immunoprecipitates; WCL, whole cell lysate; * ns, non-
specifi c. (C) In vitro binding of RLIP76∆RBD to activated 
R-Ras. GST–R-Ras was coupled to GSH–Sepharose and 
activated by addition of excess GTP or was kept nucleotide-
free in 10 mM EDTA before addition of purifi ed RLIP76 
proteins. RLIP76 bound to R-Ras in a GTP-dependent 
 manner, whereas the ∆GAPn mutant was not detected in 
R-Ras pulldowns. (D) Cell spreading was assessed as 
 before. 3T3 cells were transfected with RLIP76 siRNA, as 
indicated. HA-RLIP76 mutants were cotransfected to 
 reconstitute RLIP76 expression (fl , full-length RLIP76; au, 
arbitrary unit). Mean area measurements of GFP-positive 
cells are representative of at least three independent 
 experiments and are shown ± the SEM. (E) Cell spread-
ing in RLIP76-depleted cells reconstituted with full-length 
RLIP76 bearing an Arg232Asp point mutation in the GAP 
domain (R232D).
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 reduced RLIP76 expression failed to increase Rac activation 
in response to cell adhesion. This defect in Rac activation 
was  reversed by expression of mismatched RLIP76 (Fig. 4 B). 
Defective Rac activation in RLIP76-defi cient cells was also 
partially restored by reconstitution with RLIP76∆RBD (Fig. 
4 C), which also restored spreading (Fig. 3 D). The spreading 
defect induced by RLIP76 knockdown was reversed by expres-
sion of an activated variant of Rac (Rac1A[G12V]; Fig. 4 D). 
Furthermore, overexpression of RLIP76 failed to complement 
the spreading defect induced by dominant-negative Rac(T17N). 
Thus, Rac1 activation is downstream of RLIP76. The require-
ment for RLIP76 is specifi c to adhesion-induced Rac acti-
vation because RLIP76 depletion had little effect on Rac 
activation stimulated by EGF (Fig. 4 E). Thus, RLIP76 medi-
ates cell spreading by regulating adhesion-induced activation 
of Rac.
Rac1 activation is associated with its localization to the 
plasma membrane and concentration in nascent lamellipodia 
(Kraynov et al., 2000; Kurokawa et al., 2004). Depletion of 
RLIP76 led to diminished lamellipodial extensions and loss 
of Rac localization at the peripheral membrane. This pheno-
type was rescued by reexpression of RLIP76m (Fig. 5 A). 
 Furthermore, depletion of RLIP76 blocked lamellipodia and 
Rac membrane localization even in the presence of activated 
R-Ras(G38V) (Fig. 5 B). In contrast, RLIP76 overexpression 
rescued the loss of lamellipodia and peripheral Rac localiza-
tion in R-Ras(T43N)–transfected cells (Fig. 5 B). Thus, RLIP76 
regulates the localization and the activation of Rac GTPase.
The requirement for RLIP76 in adhesion-induced Rac 
activation suggested that RLIP76 is important for cell mi-
gration. To test this idea, we wounded monolayers of GFP-
transfected murine 3T3 cells and measured the migration of 
GFP-positive cells into the wound. Cells cotransfected with 
RLIP76 siRNA exhibited markedly impaired migration rela-
tive to control vector-transfected cells or cells cotransfected 
with the rescue construct RLIP76m in combination with the 
siRNA (Fig. 5 C). Thus, RLIP76 is required for directional cell 
migration into a wound.
RLIP76 regulates Rac activity via Arf6
Arf6 GTPase, which is a class III ADP-ribosylation factor, reg-
ulates endosomal traffi cking of Rac1 (Radhakrishna et al., 1999; 
Santy and Casanova, 2001) and mediates adhesion-dependent 
DOCK180/Elmo-induced Rac activation (Santy et al., 2005). 
Therefore, we asked if RLIP76 effects on Rac localization and 
activation are mediated by Arf6. Cell adhesion activates Arf6 
and we found that siRNA-mediated knockdown of RLIP76 
blocked adhesion-induced Arf6 activation (Fig. 6 A). We had 
previously observed (Fig. 2 C) that RLIP76 overexpression 
can bypass a requirement for R-Ras activity in cell spreading, 
Figure 4. RLIP76 regulates migration and R-Ras–induced cell spreading by controlling adhesion-induced Rac activation. (A) Rac activation induced by ad-
hesion to fi bronectin was measured as described in Materials and methods. Expression of R-Ras(G38V) promotes increased Rac activation levels, relative 
to control in cells adhering to fi bronectin, but this function is ablated by depletion of RLIP76. Overexpression of mismatched RLIP76 rescues the defect in 
Rac activation. (B) Cells were transfected as indicated, kept in suspension for 1 h, and precipitated by centrifugation (S, suspended) or plated on fi bronectin 
for the indicated times, and then adhesion-induced Rac activation was assessed. Rac activation is represented relative to levels in suspended cells (normal-
ized to 1). (C) Adhesion-induced Rac activation in RLIP76-depleted cells reconstituted with RLIP76 truncated N terminal to the RBD. (D) Quantitation of cell 
spreading in RLIP76-depleted cells expressing activated (V12) or dominant-negative (N17) Rac1. Mean area measurements of GFP-positive cells are repre-
sentative of at least three independent experiments and are shown ± the SEM. Rac(V12) rescues the spreading defect by RLIP76 depletion, whereas RLIP76 
overexpression is not suffi cient to restore spreading in Rac(N17)-expressing cells, indicating that Rac is downstream of RLIP76 in cell spreading. (E) Rac 
 activation was measured in serum-starved cells after stimulation with 10 ng/ml EGF for the indicated times.
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 suggesting that RLIP76 might render adhesion-induced Arf6 
activation independent of R-Ras. Dominant-negative R-Ras(T43N) 
inhibited adhesion-induced activation of Arf6 (Fig. 6 B); how-
ever, ectopic RLIP76 restored Arf6 activation in R-Ras(T43N)–
expressing cells (Fig. 6 B).
We next evaluated the contribution of Arf-GEFs 
to RLIP76-dependent cell spreading. Transfection of ARF 
 nucleotide-binding site opener (ARNO), which is a Sec7 
 domain–containing GEF for Arf6 (Chardin et al., 1996; Frank 
et al., 1998; Santy and Casanova, 2001), overcame the effect of 
siRNA knockdown of RLIP76 on cell spreading (Fig. 6 C), and 
this rescue could be fully reversed by expression of a domi-
nant-negative Arf6(T27N) and partially reversed by Arf1(T31N) 
(Fig. 6 C). Moreover, transfection of either dominant-negative 
Arf1 or Arf6 alone inhibited cell spreading, indicating that 
 sequestration of Arf-GEFs was suffi cient to block cell spreading. 
Furthermore, Arf6(T27N) blocked lamellipodia formation and 
peripheral localization of Rac1 (Fig. 6 D). These two results 
suggested that RLIP76 might interact with an Arf-GEF; 
indeed, we found that RLIP76 and ARNO physically associate 
in vivo (Fig. 6 E). Thus, RLIP76 links R-Ras to adhesion-
 induced Arf6 activation with consequent enhancement of the 
activation of Rac1 GTPase. Therefore, RLIP76 is a critical 
R-Ras effector in a cascade of GTPases leading to cell spreading 
and migration (Fig. 6 F).
Discussion
R-Ras has pleiotropic cellular effects, enhancing cell spreading, 
migration, and neurite outgrowth, and inhibiting cell prolifera-
tion; frequently, R-Ras effects differ from those of closely re-
lated paralogues such as H-Ras and Rap1A (Cox et al., 1994; 
Kinbara et al., 2003; Oinuma et al., 2004; Self et al., 2001). 
We used a recently developed experimental database of Ras 
GTPase–interacting proteins to identify RLIP76 (RalBP1) as an 
effector protein for R-Ras, but not for the closely related para-
logues H-Ras and Rap1. We fi nd that RLIP76 binds directly to 
R-Ras in a GTP-dependent manner and that the R-Ras–binding 
site is distinct from that of Ral. Furthermore, RLIP76 is required 
for adhesion-mediated Rac activation and cell spreading and 
migration, and for the stimulation of these processes by R-Ras. 
Arf6 GTPase is a mediator of adhesion-induced Rac activation, 
and RLIP76 is needed for adhesion-induced activation of Arf6. 
Reconstitution of Arf6 activity by transfection with an Arf6–
guanine nucleotide exchange factor (GEF), ARNO restored Rac 
activation and cell spreading in RLIP76-depleted cells. Thus, 
we identify a new R-Ras effector, RLIP76, which is a critical 
link in a cascade of three GTPases that regulates cell spreading 
and migration.
The proteomic strategy used in this study identifi ed RLIP76 
as a candidate R-Ras effector, and subsequent studies established 
Figure 5. RLIP76 is required for Rac membrane localiza-
tion and lamellipodia. (A) Cells were transfected with GFP 
and control siRNA (a), RLIP76 siRNA (b), or RLIP76 siRNA 
and RLIP76m (c), and peripheral membrane Rac localiza-
tion was assessed in cells spread on fi bronectin by immuno-
staining with antibodies to Rac1. Arrows point to areas 
of Rac enrichment in lamellipodia. GFP-positive cells are 
indicated by asterisks. Percentages of GFP-positive cells 
showing Rac membrane localization are shown. Bar, 10 μm. 
(B) Cells were transfected with GFP and R-Ras(T43N) 
(a), R-Ras(T43N) and RLIP76m (b), or R-Ras(G38V) and 
RLIP76 siRNA (c). Percentages of cells showing Rac mem-
brane localization are shown. (C) Directional migration of 
RLIP76-depleted cells into a scratch wound. Cells were 
plated on fi bronectin-coated substrates, a single scratch 
was made in confl uent cell monolayers 48 h after transfec-
tion, and GFP-positive cells were tracked microscopically 
over 4 h. The mean distances traveled into the wound 
space by GFP-positive cells at the wound edge (at least 
25 cells/sample) are shown ± the SEM.
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that it is an authentic effector that mediates the activities of R-Ras 
in cell spreading. In particular, RLIP76 binding to R-Ras was di-
rect and specifi c for the GTP-bound form of R-Ras. Moreover, 
we previously identifi ed a switch 1 domain mutation (D64A) that 
perturbs R-Ras interaction with effectors such as RalGDS, Raf1, 
NORE1, and PI3-kinase (Oertli et al., 2000). This mutation did 
not block interaction with RLIP76, nor did it block the effect of 
R-Ras on cell spreading, thus, implicating RLIP76 as a previ-
ously proposed (Kinashi et al., 2000; Oertli et al., 2000) novel 
R-Ras effector. In contrast, the R-Ras(D64E) mutant was defi -
cient in binding to RLIP76 and did not promote spreading, 
 suggesting that the R-Ras–RLIP76 interaction involves the effec-
tor-binding region of R-Ras. Collectively, these data indicate that 
RLIP76 is an authentic R-Ras effector that mediates R-Ras stim-
ulation of cell spreading; suppression of cell spreading by siRNA-
induced RLIP76 depletion confi rmed this conclusion.
RLIP76 binds R-Ras, but not the closely related Ras 
 proteins H-Ras or Rap-1. This distinguishes RLIP76 from 
 effectors such as Raf-1, RalGDS, PI3-kinase, and NORE1 that 
bind to multiple Ras family members (Marshall, 1996; Campbell 
et al., 1998; Oertli et al., 2000). Recently, Ada-Nguema 
et al. (2006) showed that PLCε interacts with activated 
R-Ras(G38V) better than wild-type R-Ras, although a direct 
interaction was not demonstrated. However, PLCε can also bind to 
other Ras isotypes through its Ras-association domain (Bunney 
et al., 2006). It seems likely that our success in identifying the 
RLIP76 interaction may be attributable to the use of prenylated 
R-Ras in mammalian cells. Most previous studies have used 
yeast two-hybrid approaches in which the Ras  protein is neither 
posttranslationally modifi ed nor appropriately localized (Gietz 
et al., 1997). The posttranslational modifi cation and localiza-
tion of Ras proteins has a critical effect on their interactions and 
Figure 6. RLIP76 regulates spreading through 
the activation of Arf6. (A) Loss of adhesion-
 induced Arf6 activation in the absence of 
RLIP76. NIH 3T3 cells were transfected with 
vector and control siRNA (Vec), RLIP76 siRNA 
(si), or siRNA and RLIP76m (si + R), and after 
24 h were detached and either kept in suspen-
sion or plated on fi bronectin. Arf6 activation 
was measured as described in Materials and 
methods. (B) RLIP76 bypasses the requirement 
for R-Ras activity in adhesion-induced Arf6 
 activation. NIH 3T3 cells were transfected as 
indicated, and Arf6 activation was measured 
as in A. (C) The Arf-GEF ARNO rescues the 
spreading defect in RLIP76-depleted cells. 3T3 
cells were transfected as indicated and plated 
on fi bronectin-coated coverslips for spreading 
assays. Arf(TN) mutants are indicated as 
1 (Arf1[T31N]) or 6 (Arf6[T27N]). Mean area 
measurements of GFP-positive cells are repre-
sentative of at least three independent experi-
ments and are shown ± the SEM. (D) Association 
of ARNO with RLIP76. Cells were cotrans-
fected with either FLAG-ARNO or HA-Arf6, 
and RLIP76 was precipitated from cell lysates 
with anti-RLIP76 antibodies. ARNO was pre-
sent in RLIP76 precipitates and not detected 
in an irrelevant IgG control, whereas Arf6 
was not detected in either immunoprecipitate. 
 Images of the Arf6 and ARNO immunoblots 
are derived from the same exposure of one 
gel that was cut to remove an intervening 
marker lane. IP, immunoprecipitates; WCL, 
whole cell lysate. (E) Cells were transfected 
with Arf6(T27N), and peripheral membrane 
Rac localization was assessed in cells spread 
on fi bronectin by immunostaining with anti-
bodies to Rac1. Arrows point to areas of Rac 
enrichment in lamellipodia. GFP-positive cells 
are indicated by asterisks. 11% of GFP-positive 
cells showed peripheral membrane Rac 
 localization in Arf6(T27N)-transfected cells, 
compared with 72% of GFP-positive control-
transfected cells. Bar, 10 μm. (F) RLIP76 is a 
central component of a GTPase cascade 
 linking Ras to Arf and Rho family GTPases. 
 Activated R-Ras couples to RLIP76, leading to 
Arf6 activation, which promotes adhesion-
 induced GTP loading of Rac1 leading to cell 
spreading and migration.
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resulting biological functions (Hancock, 2003); indeed, this 
principle has been experimentally demonstrated for R-Ras 
(Oertli et al., 2000; Hughes et al., 2001; Hansen et al., 2003). 
RLIP76 binds the small GTPase, RalA (Cantor et al., 1995; 
Jullien-Flores et al., 1995; Park and Weinberg, 1995; Matsubara 
et al., 1997; Lebreton et al., 2004); however, RalA is not in-
volved in R-Ras–RLIP76–mediated cell spreading. An acti-
vated R-Ras effector loop mutant that does not bind RalGDS 
(G38VD64A; Oertli et al., 2000) still promoted cell spreading. 
In addition, the RBD of RLIP76 was not required for direct 
binding to R-Ras. This fi nding is consistent with earlier struc-
ture–function studies in which the RLIP76 RBD did not bind to 
Ras (Bauer et al., 1999). Indeed, the RBD is predicted to form 
a coiled coil, unlike the ubiquitin fold common to RBDs, sug-
gesting that RLIP76 interacts with R-Ras through a structural 
mechanism that is distinct from the canonical interactions of 
Ras proteins with effectors (Bauer et al., 1999). The RLIP76 
RBD was also not required for Rac activation or cell spreading. 
Thus, RLIP76 is a bona fi de R-Ras–specifi c effector that medi-
ates R-Ras–stimulated cell spreading.
RLIP76 promotes cell spreading by mediating adhesion-
dependent activation of Rac GTPase. Specifi cally, adhesion-
 dependent spreading and Rac activation required RLIP76. 
Furthermore, activated Rac1(G12V) rescued the spreading de-
fect in RLIP76-depleted cells, and RLIP76 overexpression did 
not restore spreading in cells expressing dominant-negative 
Rac1(T17N); hence, RLIP76 is upstream of adhesion-mediated 
Rac activation. The RhoGAP domain of RLIP76 was important 
in its ability to mediate adhesion-dependent Rac activation. This 
domain, which is similar to the GAP domains of Bcr-GAP and 
n-chimaerin (Jullien-Flores et al., 1995; Park and Weinberg, 
1995), has been reported to act as a Rac and Cdc42 GAP in vitro 
(Jullien-Flores et al., 1995; Park and Weinberg, 1995; Matsubara 
et al., 1997). Nevertheless, our studies show that in vivo, RLIP76 
is required for adhesion-induced activation of Rac, and this 
function is insensitive to a mutation of the arginine fi nger of 
the RhoGAP domain that is predicted to disrupt GAP activity 
(Bourne, 1997). Furthermore, forced targeting of RLIP76 to the 
plasma membrane causes extensive membrane ruffl ing and pro-
trusive activity, which are Rac-dependent processes (Lebreton 
et al., 2004), which is consistent with a positive role in Rac 
 activation. Thus, these data show that RLIP76 is upstream of 
adhesion-dependent Rac activation that leads to cell spreading.
RLIP76 mediates adhesion-dependent Rac activation and 
cell spreading by regulating Arf6 GTPase. Cell adhesion acti-
vated Arf6, which is a small GTPase known to participate in 
adhesion-mediated Rac activation (Santy and Casanova, 2001) 
and cell spreading. Furthermore, enforced activation of Arf 
GTPases by an Arf-GEF (ARNO) rescued spreading in RLIP76-
depleted cells, establishing that Arf6 activation can bypass the 
requirement for RLIP76. ARNO activates both Arf1 and Arf6; 
however, only Arf6 can act at the plasma membrane to promote 
Rac activation (Al-Awar et al., 2000; Santy and Casanova, 
2001), implicating Arf6 as the major target of ARNO in cell 
spreading (Santy et al., 2005). However, ARNO is an exchange 
factor for both Arf1 and Arf6, and we found that dominant-
negative Arf6(T27N) and Arf1(T31N) both reduced the ability 
of ARNO to rescue spreading in RLIP76-depleted cells. Previ-
ous studies implicated Arf6 in adhesion-dependent Rac activation 
(Santy and Casanova, 2001; Nishiya et al., 2005), possibly 
 because Arf6 activity is necessary for delivery of Rac to the 
plasma membrane (Radhakrishna et al., 1999; Al-Awar et al., 
2000; Boshans et al., 2000) and Arf6 is implicated in ARNO-
mediated recruitment of the Rac-GEF, DOCK180/Elmo (Santy 
et al., 2005). Furthermore, we found that RLIP76 interacts with 
ARNO in cells, suggesting a physical as well as a functional 
connection between RLIP76 and Arf-GEF activity. RLIP76 has 
been shown to mediate glutathione conjugate transport activity 
and to be localized to the cell surface (Yadav et al., 2004). Our 
results describe an additional signaling function for RLIP76 
in the cytosol. Thus, Arf6 acts between RLIP76 and Rac in 
 adhesion-mediated cell spreading; moreover, the capacity of Arf6 
to  regulate Rac localization and activity provides a plausible 
mechanism for its role in RLIP76-dependent cell spreading.
In sum, our data establish that RLIP76 is a new R-Ras ef-
fector that connects R-Ras to the activation of Arf6 and, conse-
quently, to Rac1 leading to adhesion-dependent cell spreading 
and migration (Fig. 6 F). Furthermore, the multiple functions of 
RLIP76 may account for the pleiotropic effects of R-Ras. For 
example, the RLIP76-dependent activation of Rac GTPase may 
contribute to the ability of R-Ras to promote cell migration and 
neurite outgrowth, which are processes that are known to de-
pend on Rac (Keely et al., 1999; Ivins et al., 2000; Holly et al., 
2005). Also, RLIP76 mediates the adhesion-induced activation 
of Arf6 GTPase, which is a regulator of vesicle traffi cking 
 (Radhakrishna and Donaldson, 1997); hence, regulation of Arf6 
may contribute to the ability of RLIP76 to control endocytosis 
(Jullien-Flores et al., 2000). Indeed, RLIP76 physically associ-
ates with the μ2 chain of AP-2, which is an adaptor whose 
membrane recruitment is controlled by Arf6, suggesting that 
these two proteins can coordinately regulate clathrin-mediated 
endocytosis (Jullien-Flores et al., 2000; Paleotti et al., 2005). 
Endocytosis of growth factor receptors can limit their ability to 
stimulate cell proliferation (Ceresa and Schmid, 2000); there-
fore, the interaction of RLIP76 with R-Ras may explain the 
 capacity of R-Ras to limit the proliferation of endothelial and 
smooth muscle cells (Komatsu and Ruoslahti, 2005). R-Ras can 
have complex and differing effects on apoptosis, cell adhesion, 
and migration, depending on cellular context (Wang et al., 1995; 
Zhang et al., 1996; Keely et al., 1999; Ohba et al., 2001; Kinbara 
et al., 2003; Kwong et al., 2003; Holly et al., 2005; Wozniak 
et al., 2005). The capacity of R-Ras to interact with RLIP76, 
and thereby regulate Arf6, links R-Ras to the regulation of vesicle 
traffi cking and helps to explain its wide-ranging effects on cell 
growth, apoptosis, cell adhesion, and cell migration.
Materials and methods
Antibodies and reagents
Monoclonal anti-Rac1 antibody (23A8) was obtained from Millipore. Goat 
anti–human RalBP1 (RLIP76), rabbit anti–R-Ras, goat anti-MLCKsk, mouse 
monoclonal anti-Arf6, and rabbit H-15 anti–His tag antibodies were pur-
chased from Santa Cruz Biotechnology, Inc. Monoclonal anti-HA antibody 
was obtained from Covance. Restriction endonucleases were obtained 
from New England Biolabs.
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Cell lines and transfections
NIH 3T3 cells (American Type Culture Collection) were maintained in DME 
(Cellgro) supplemented with 10% FBS, 2 mM L-glutamine, 50 U/ml penicil-
lin, 50 μg/ml streptomycin sulfate, and 1% nonessential amino acids 
(Sigma-Aldrich) at 37°C in 5% CO2. Cells were transfected with plasmids 
using Lipofectamine reagent (Invitrogen) following the manufacturer’s in-
structions. Cells were analyzed 48 h after transfection. For cotransfection 
with siRNA after plasmid transfection, the medium was changed to com-
plete DME without antibiotics after plasmid transfection and the cells were 
cultured for 24 h. Cells were subsequently transfected with siRNA as 
 described below and cultured for an additional 24 h before analysis. 
For siRNA-mediated RLIP76 knockdown, complementary single-strand RNAs 
(G U A G A G A G G A C C A U G A U G dTdT and A C A U C A U G G U C C U C U C U A C-
dTdT) targeting human and mouse RLIP76 were purchased from Invitrogen 
and dissolved in TE (10 mM Tris-Cl, pH 7.5, 0.1 mM EDTA). Sequence-
scrambled complementary single-strand RNAs were also obtained (G A A G-
A A G A U C G U C A G U G G dTdT and C C A C U G A C G A U C U U C U U C dTdT). 
Double-stranded RNA was generated by annealing the RNAs in annealing 
buffer (100 mM KOAc, 30 mM Hepes-KOH, pH 7.4, and 2 mM MgOAc). 
Formation of double-stranded RNA was confi rmed by polyacrylamide gel 
electrophoresis. For siRNA-mediated knockdown of RLIP76, 3T3 cells were 
maintained overnight in complete DME with 10% FBS, but without antibi-
otics. Cells were transfected with Lipofectamine 2000 in Opti-MEM (Invit-
rogen) according to the manufacturer’s instructions. Cells were analyzed 
24 h after transfection.
Complementary DNAs
pEGFP-C1 was obtained from CLONTECH Laboratories, Inc. pEGFP-C1-
Rac1 WT was a gift from M. del Pozo (Fundación Centro Nacional de 
Investigaciones Cardiovasculares, Madrid, Spain). N-terminal TAP-tag 
fusions of human Ras isotype variants were made by subcloning human 
cDNAs of R-Ras, H-Ras, and Rap1A containing the indicated mutations 
(Oertli et al., 2000) into the N-terminal TAP vector (a gift from B. Séraphin, 
European Molecular Biology Laboratory, Heidelberg, Germany) using 
BamH1–Xba1 sites. J. Han provided the nTAP-H-Ras and –Rap1A plas-
mids. The human RLIP76 cDNA was obtained from the American Type 
Culture Collection. An oligodeoxyribonucleotide encoding a 5′ infl uenza 
HA tag joined to six bases from the 5′ end and another oligodeoxyri-
bonucleotide complementary to the 3′ end of RLIP76 (5′-RLIP76: 5′-G G-
A G A T A T C G G C G T C A T G T A C C C A T A C G A T G T T C C A G A T T A C G C T C T C G A-
G A T G A C T T G C T T C C T G C C C C C C A C C A G C -3′ and 3′-RLIP76: 5′-C G C-
A A C C T T G C T C A G A T G G A C G T C T C C T T C C T A T C C C T G C T G G G -3′) were 
obtained from GenBase. The oligodeoxyribonucleotides were used in a 
PCR reaction to amplify HA-tagged RLIP76 from the RLIP76 cDNA. The 
PCR product was sequenced and cloned into pcDNA3.1(−) (Invitrogen) 
using EcoRV and HindIII sites. HA-tagged RLIP76 truncation and deletion 
plasmids were generated by PCR from the HA-RLIP761/pcDNA3.1(−) 
template using the following primer sets: ∆RBD (truncated at amino acid 
392): 5′-RLIP76 and 5′-G G C T G A T G G A T C C T T G A T G C C C G C C T A G G T-
C T C T G G C A G C G T G G G -3′; and ∆GAP-n (truncated at amino acid 292): 
5′-RLIP76 and 5′-C G C A A G C T T T T A C T G C T T C A G C A A A C T G G A -3′. 
HA-RLIP76/3.1(−) mismatch construct was produced by QuikChange 
mutagenesis (Stratagene) according to the manufacturer’s instructions, 
using the primers: 5′-G G C T G A T G C A G T C G A A G A A C T A T G A T G T A T G A T G-
G C A T T C G G C T G C C A G C C -3′ and 5′-C C T T A A G G A A A C C G A C T A C G T C-
A G C T T T C T T G A T A C T A C A T A C T A C C G T A A G C C -3′. HA-RLIP76-RD/3.1(−) 
Arg232Asp mutant was also produced by QuikChange mutagenesis, using 
the primers: 5′-G G C A T G A A G T G T G A A G G C A T C T A C G A C G T A T C A G G A A-
T T A A A T C A A A G -3′ and 5′-C C T T G A T T T A A T T C C T G A T A C G T C G T A G A T G-
C C T T C A C A C T T C A T G C C -3′. 6-His-tagged RLIP76 constructs were made 
by Xba1–HindIII digestion of the appropriate constructs in pcDNA3.1(−) 
and ligation into Xba1–HindIII–digested pRSET(A) vector (Invitrogen). The 
GST–R-Ras(wt) plasmid was as previously described (Oertli et al., 2000). 
HA-tagged Arf expression constructs were a gift from J. Casanova (Univer-
sity of Virginia, Charlottesville, VA).
TAP of R-Ras protein complexes and identifi cation of binding proteins
TAP of TAP–R-Ras protein complexes was performed as described at the 
National Cell Migration Consortium website (http://demo.cellmigration.
org/resource/discovery/ginsberg_tap_appr.shtml).
Solution-based digestion: The TAP-purifi ed protein samples were 
treated with 10 μl of 200 mM CaCl2 and 20 μl of 100 mM ammonium 
 bicarbonate. Reduction of the disulfi de bonds in the proteins was accom-
plished by treatment of the samples with 1 μl DTT (20 mM fi nal) for 1 h at 
52°C, followed by carboxyamidation by treatment with 1 μl iodoacetamide 
(40 mM fi nal) for 1 h at RT in the dark. Proteolytic digestion of the reduced 
and alkylated sample was conducted by addition of 1 μl of modifi ed tryp-
sin (0.5 μg; Promega) and incubating the mixture at 37°C for 9 h. The di-
gestion was quenched by acidifi cation with 2 μl of glacial acetic acid and 
frozen at −35°C until further analysis.
Analysis by mass spectrometry: For the identifi cation of interacting 
proteins, the digested samples were loaded onto a C18 column. Peptides 
were analyzed by nanofl ow reverse-phase high-performance liquid chro-
matography microelectrospray tandem mass spectrometry (RP-HPLC/μESI/
MS/MS) interfaced with a Finnigan LCQ ion trap mass spectrometer 
(Thermo Electron Corp.). Peptides were gradient-eluted using a linear gra-
dient of 0–60% B in 120 min (A, 0.1 M acetic acid in NANOpure water; 
B, 70% acetonitrile in 0.1 M acetic acid). The LTQ spectrometer was oper-
ated in a data-dependent top 10 MS/MS mode. The data was then 
searched against a human, rat, and mouse GenBank protein database com-
piled by National Center for Biotechnology Information (http://www.ncbi.
nlm.nih.gov/Sitemap/ResourceGuide.html#FTPSite), using the  SEQUEST 
search algorithm (version 27; Link et al., 1999). Peptide sequence assign-
ments were verifi ed by manual interpretation of MS/MS spectra.
Recombinant proteins
To produce 6-His-tagged RLIP76 proteins and GST–R-Ras(wt), 1 mM IPTG 
was added to a suspension containing BL21/pLys(s)-DE3 (Stratagene) bac-
teria (OD = 0.5) bearing the appropriate plasmid, and the bacteria were 
incubated with continuous shaking at 37°C for 4 h. Bacteria were lysed by 
sonication in lysis buffer (GST–R-Ras: 20 mM Tris-Cl, pH 7.0, 150 mM 
NaCl, 1 mM MgCl2, 1% Triton X-100, 1 mM DTT, 5 mg/ml lysozyme, and 
protease inhibitors; His-tagged proteins: 20 mM Tris-Cl, pH 7.9, 5 mM 
 imidazole, 500 mM NaCl, 0.1% NP-40, 5 mg/ml lysozyme, and protease 
inhibitors) and centrifuged at 39,000 g for 20 min, and the soluble  proteins 
were purifi ed on Ni2+-coupled Sepharose (His-tagged proteins; Novagen) 
or GSH-Sepharose (R-Ras; Roche), according to the manufacturer’s instruc-
tions. GST-PBD protein was generated and purifi ed as in del Pozo et al. 
(2000). GST-GGA3VHS-GAT was generated and purifi ed as in Santy and 
 Casanova (2001).
Cell-spreading assays and microscopy
Glass coverslips were incubated with 5 μg/ml plasma fi bronectin in 0.1 M 
NaHCO3 at 4°C overnight; after washing, the coverslips were incubated 
for 30 min with 1% BSA/PBS that had been heat inactivated by incubation 
at 80°C for 30 min to block unreacted sites. Cells were detached with 
0.1% trypsin and kept in suspension for 1 h at RT in DME containing 0.2% 
BSA, and then plated on the coated coverslips for 45 min at 37°C. Nonad-
herent cells were removed by washing two times with PBS, and the adher-
ent cells were fi xed in 3.7% formaldehyde/PBS for 20 min at RT. Fixed 
cells were washed and permeabilized with 0.1% Triton X-100/PBS for 
5 min, washed with PBS, and incubated with 5 μg/ml rhodamine-phalloidin 
(Invitrogen) in PBS at 37°C for 1 h. Coverslips were washed and mounted 
on slides with ProLong Gold antifade reagent (Invitrogen) and imaged on 
an epifl uorescence microscope (DMLS; Leica) fi tted with a SPOT charge-
coupled device camera (Diagnostic Instruments). The area of GFP-positive 
cells was measured using ImageJ software (National Institutes of Health).
Migration assays
Cells were transfected and plated on fi bronectin-coated dishes as de-
scribed in the previous section. 48 h after transfection, cell monolayers 
were scratched with a pipette tip. Cells were maintained in complete me-
dium at 37°C in 6% CO2, and images were taken at 30 min intervals for 
4 h. Cell centroid movements of GFP-positive cells were tracked in succes-
sive images using ImageJ software.
Rac activation assays
Adhesion-dependent Rac activation was measured following the method of 
del Pozo et al. (2000). Cells were transfected as indicated, and cultured in 
MEM/0.2% FBS overnight. Cells were detached and maintained in sus-
pension for 1 h at RT. The cells were plated on prewarmed, fi bronectin-
coated dishes, incubated at 37°C with 6% CO2 for the indicated times, 
rinsed briefl y with ice-cold PBS, and scraped into Rac assay lysis buffer 
(50 mM Tris-Cl, pH 7.0, 0.5% NP-40, 500 mM NaCl, 1 mM MgCl2, 1 mM 
EGTA, 100 mM Na3VO4, and protease inhibitors) containing 5 μg/
sample GST-PBD protein. Cell lysates were cleared of insoluble material 
by centrifugation and incubated with GSH–Sepharose for 30 min. The 
Sepharose beads were pelleted, washed three times with ice-cold lysis 
 buffer (without GST-PBD), and resuspended in SDS gel-loading buffer. 
Bead-bound proteins were extracted by boiling, and the protein samples 
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were separated by SDS-PAGE. Proteins were transferred to nitrocellulose 
membrane, and Rac was detected by Western blotting with 23A8 anti-Rac 
antibody (Millipore).
Arf6 activation assays
Cells were detached and kept in suspension for 1 h in serum-free DME con-
taining 0.2% BSA. Cells were then plated on dishes coated with 5 μg/ml 
fi bronectin. After 5 min, cells were lysed and GTP-bound Arf6 was assayed 
by its binding to a GST-fusion protein containing the VHS domain to the 
GAT region of an Arf effector, GGA3 (Golgi-localized, γ-ear-containing 
Arf-binding protein 3; GST-GGA3VHS-GAT; Dell’Angelica et al., 2000), 
as previously described (Santy and Casanova, 2001).
Immunoprecipitation and in vitro binding experiments
Coprecipitations: Cells were plated and transfected as in Cell lines and 
transfections, and maintained in complete DME. After 48 h, cell lysates were 
harvested by scraping in TEV protease cell lysis buffer (TEVCB). Lysates 
were maintained at 4°C and insoluble material was removed by centrifuga-
tion at 14,000 rpm for 10 min. For coprecipitations with TAP-tagged 
 constructs, supernatants containing soluble material were incubated with 
IgG-coupled Sepharose (Roche) for 1 h at 4°C. The Sepharose beads were 
pelleted by centrifugation and washed three times in TEVCB; then the bead-
bound material was extracted in SDS buffer and separated by SDS-PAGE, 
followed by Western blotting with the appropriate antibodies. For coimmu-
noprecipitation experiments, cell lysates were precleared by incubation 
with protein G–Sepharose for 1 h at 4°C. Cleared lysates were incubated 
for an additional hour with 1 μg of the appropriate antibody, followed by 
antibody capture on protein G–Sepharose beads for 1 h. Antibody-bound 
complexes were precipitated by centrifugation, washed, and separated by 
SDS-PAGE, followed by Western blotting with relevant antibodies.
In vitro binding assays: GST–R-Ras was bound to glutathione–
 Sepharose beads (Roche) by incubation for 1 h at 4°C and coupled to GTP 
by an  additional hour with 10 μM GTP, or kept inactive by addition of 
10 mM EDTA. Recombinant RLIP76 proteins were added at 300 nM each 
in 1 ml of TEVCB for 1 h at 4°C. Beads were washed with buffer three 
times, and the bound proteins were separated by SDS-PAGE and detected 
with anti-His or anti–R-Ras antibodies.
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